Metropolitan Life Insurance Co. NY Boosts Stake in Teladoc Health Inc (TDOC)

Metropolitan Life Insurance Co. NY increased its holdings in shares of Teladoc Health Inc (NYSE:TDOC) by 360.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,799 shares of the health services provider’s stock after purchasing an additional 17,061 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Teladoc Health were worth $1,081,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in TDOC. SG Americas Securities LLC lifted its holdings in Teladoc Health by 665.4% in the third quarter. SG Americas Securities LLC now owns 22,793 shares of the health services provider’s stock worth $1,968,000 after purchasing an additional 19,815 shares during the period. Swiss National Bank lifted its holdings in Teladoc Health by 1.2% in the third quarter. Swiss National Bank now owns 97,900 shares of the health services provider’s stock worth $8,454,000 after purchasing an additional 1,200 shares during the period. Bank of New York Mellon Corp lifted its holdings in Teladoc Health by 11.8% in the third quarter. Bank of New York Mellon Corp now owns 525,875 shares of the health services provider’s stock worth $45,410,000 after purchasing an additional 55,522 shares during the period. American International Group Inc. lifted its holdings in Teladoc Health by 10.0% in the third quarter. American International Group Inc. now owns 44,462 shares of the health services provider’s stock worth $3,839,000 after purchasing an additional 4,043 shares during the period. Finally, DekaBank Deutsche Girozentrale lifted its holdings in Teladoc Health by 47.1% in the third quarter. DekaBank Deutsche Girozentrale now owns 12,500 shares of the health services provider’s stock worth $949,000 after purchasing an additional 4,000 shares during the period.

A number of brokerages have weighed in on TDOC. Robert W. Baird raised shares of Teladoc Health from a “neutral” rating to an “outperform” rating and set a $80.00 price target for the company in a report on Monday, January 14th. They noted that the move was a valuation call. Berenberg Bank began coverage on shares of Teladoc Health in a report on Thursday, January 31st. They issued a “buy” rating and a $80.00 price target for the company. Cantor Fitzgerald reissued a “hold” rating and issued a $70.00 price target (down from $83.00) on shares of Teladoc Health in a report on Wednesday, February 27th. Zacks Investment Research raised shares of Teladoc Health from a “sell” rating to a “hold” rating in a report on Monday, April 1st. Finally, SunTrust Banks upped their price objective on shares of Teladoc Health to $75.00 and gave the company a “positive” rating in a research note on Monday, March 4th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. Teladoc Health presently has an average rating of “Buy” and an average price target of $81.50.

In other news, SVP Andrew Turitz sold 31,960 shares of the company’s stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $55.82, for a total value of $1,784,007.20. Following the transaction, the senior vice president now owns 13,455 shares in the company, valued at approximately $751,058.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jason N. Gorevic sold 30,000 shares of the company’s stock in a transaction dated Tuesday, April 16th. The shares were sold at an average price of $53.04, for a total value of $1,591,200.00. Following the completion of the transaction, the chief executive officer now owns 673,924 shares in the company, valued at approximately $35,744,928.96. The disclosure for this sale can be found here. Insiders sold a total of 164,221 shares of company stock worth $9,944,891 in the last quarter. 3.95% of the stock is owned by corporate insiders.

Shares of TDOC traded up $1.74 during trading hours on Friday, reaching $51.60. The company’s stock had a trading volume of 2,162,242 shares, compared to its average volume of 1,861,303. The company has a market capitalization of $3.65 billion, a price-to-earnings ratio of -35.83 and a beta of 1.40. Teladoc Health Inc has a 1-year low of $40.00 and a 1-year high of $89.05. The company has a debt-to-equity ratio of 0.41, a current ratio of 8.53 and a quick ratio of 8.53.

TRADEMARK VIOLATION NOTICE: “Metropolitan Life Insurance Co. NY Boosts Stake in Teladoc Health Inc (TDOC)” was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.baseballdailydigest.com/news/2019/04/21/metropolitan-life-insurance-co-ny-increases-position-in-teladoc-health-inc-tdoc.html.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: How to find the components of the quick ratio

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.